Treatment of Tinea Corporis

Introduction to Treatment

The American Academy of Dermatology recommends topical antifungal therapy as the first-line treatment for localized tinea corporis, with allylamine agents (terbinafine or naftifine) applied once daily for 1-2 weeks being preferred over azoles due to shorter treatment duration 1, 2

Topical therapy alone is appropriate for localized, limited skin involvement in immunocompetent patients without treatment failure 1, 2
Allylamine antifungals, such as terbinafine 1% cream applied once daily for 1-2 weeks, are preferred due to their shorter treatment duration compared to azoles 2

Oral antifungal therapy is indicated when the infection is extensive or resistant to topical treatment, or in immunocompromised patients 1, 2
Terbinafine is the first-line oral agent, with a dosage of 250 mg daily for 1-2 weeks, and achieves an 87.1% mycological cure rate at 6 weeks follow-up 1, 2
Itraconazole is an alternative oral agent, with a dosage of 100 mg daily for 15 days, and achieves an 87% mycological cure rate 1, 2

The American Academy of Dermatology recommends confirming diagnosis before treatment by performing potassium hydroxide (KOH) preparation or fungal culture to identify the causative organism 1, 2

Mycological cure, not just clinical response, is the definitive treatment endpoint, and follow-up with repeat mycology sampling until clearance is documented is necessary 1, 2

Essential preventive measures include screening and treating all family members, as over 50% of household contacts may be affected with anthropophilic species like T. tonsurans 1, 2
Cleaning all fomites (combs, brushes, towels) with disinfectant or 2% sodium hypochlorite solution is also recommended 1, 2

Griseofulvin should not be used as first-line therapy due to its longer treatment duration and lower efficacy compared to terbinafine 1

Terbinafine demonstrates high activity against Trichophyton tonsurans infections, making it a preferred oral agent for this common anthropophilic dermatophyte 3.
Itraconazole 100 mg once daily for 15 days yields an 87 % mycological cure rate, which is significantly higher than the 57 % cure rate observed with griseofulvin, supporting its use as an effective alternative oral therapy 3.

Screening and treating all household contacts is essential, as more than 50 % of family members may be colonized with anthropophilic species such as T. tonsurans 3.
Avoid direct skin‑to‑skin contact with infected individuals and keep active lesions covered to reduce the risk of spread within close‑contact settings 3.
Do not share towels, combs, brushes, or other personal items, as these fomites can transmit the fungus among household members 3.